Alaskas Oil Revival Drives Renewed Arctic Investment and Exploration Japans Nikkei 225 Hits Record High as Hong Kong and South Korean Markets Remain Closed for Holidays Oil Prices Decline as USIran Peace Talks Raise Hopes for Strait of Hormuz Reopening Barnes Noble CEO James Daunt Clarifies Booksellers Position on AIGenerated Books A Straightforward Rejection Bitcoin Below 100000 Market Dynamics and Investor Considerations Singapore Core Inflation Unexpectedly Eases to 14 in April PL Earnings Overview 20260527 Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path LFWD Q1 2026 Earnings Significant EPS Miss Despite Stock Rally STEX Q1 2026 Earnings Significant EPS Miss as Streamex Corp Reports WiderThanExpected Loss MBIN Q1 2026 Earnings EPS Beats Estimates by 5 Amid Mixed Market Reaction BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Negative EPS Highlights Operational Strain as Bond Price Edges Higher Babcock Wilcox 2026 Notes BWNB Edge Lower Amid Quiet Trading Intellia Therapeutics Slides Slightly Amid Cautious Trading in GeneEditing Sector GGT Rises Slightly as It Holds Above Key Support Gabelli MultiMedia Trust Consolidates Title Virtus Total Return Fund ZTR Nears Support as Modest Decline Tests 676 Level ArtsWay Manufacturing Co Inc ARTW Faces Pressure Tests Key Support Level UK Exports to US Plunge 25 Following Trumps Liberation Day Tariffs Trade Balance Turns to Deficit ARR Q1 2026 Earnings EPS Beats Estimates Amidst a Choppy Rate Environment POSCO Holdings PKX Steadies Near Support as Steel Market Dynamics Shift Millrose Properties MRP Holds Steady Near Support as Consolidation Phase Emerges Cardinal Infrastructure Group CDNL Surges 39 Key Levels to Watch Jianzhi Education Technology Group JZ Edges Higher Amid Modest Uptick as Shares Hold Above Key Support Adams Natural Resources Fund PEO Holds Steady Near 2643 After Marginal Gain XBiotech Inc XBIT Edges Higher Amid Steady Biotech Sector Activity Vertex Inc VERX Rallies 2 as Stock Approaches Key Resistance Zone Acurx Pharmaceuticals ACXP Holds Near Key Support as Small Decline Signals Consolidation